Login Register

Access the GIFSQ Portal

Select your user type to log in or register a new account.

Student Portal

Access your food safety courses, certifications, and exams.

Instructor Portal

Manage courses, view student submissions, and grade quizzes.

Company Portal

Manage corporate setup, view employee logs, and access QA services.

Viruses That Kill Listeria: Phage Biocontrol Explained

The study: Leverentz B, et al. (2003). Biocontrol of Listeria monocytogenes on fresh-cut produce by treatment with lytic bacteriophages and a bacteriocin. Applied and Environmental Microbiology, 69(8), 4519–4526. DOI: 10.1128/AEM.69.8.4519-4526.2003.

Bacteriophages — viruses that infect bacteria — are the most abundant biological entities on Earth, and some of them specialize in killing Listeria. The idea: apply phage preparations to RTE foods or food-contact surfaces, where they hunt down L. monocytogenes specifically, leaving everything else alone. It’s biocontrol with sniper precision.

What the research demonstrated

Phage treatments typically achieved 1- to 3-log reductions of L. monocytogenes on RTE meats, cheeses, and other products in published studies. The specificity is the selling point: phages hit Listeria and essentially nothing else — no effect on flavor, no broad-spectrum disruption, no chemical residues. They work at refrigeration temperatures, right where Listeria is the problem. FDA GRAS notices for anti-Listeria phage preparations gave the regulatory green light for specific uses. Limitations: phages need to physically contact their targets (no residual magic), bacterial resistance can develop (hence phage cocktails), and they’re an added hurdle, not a standalone solution.

Fitting phages into a Listeria program

Think of phage as a targeted supplement to your existing controls — not a replacement for sanitation, environmental monitoring, or formulation hurdles. Where it shines: RTE products with meaningful shelf lives where Listeria growth is the concern and other interventions are maxed out. The studies support real, if modest, reductions. Our advice: validate in your product (phage efficacy is matrix- and strain-dependent), use cocktail preparations to slow resistance, and keep your foundational controls strong. Phages are precision tools — they work best in a program that’s already disciplined.

Where phage products fit — and where they don’t

Bacteriophage preparations for Listeria control earned regulatory acceptance in several jurisdictions as processing aids, which moved them from research curiosity to purchasable tool. But their niche is specific, and misunderstanding it leads to disappointment. Phages are a surface treatment for ready-to-eat products — applied to the food, they reduce Listeria on contact. They are not an environmental sanitation tool, not a substitute for hygienic design, and not a fix for a contaminated plant. A facility with harborage sites will recontaminate product faster than any surface treatment can compensate.

Specificity is both the strength and the limitation. Phages attack their target species and leave everything else alone — no broad-spectrum collateral, no sensory impact, no chemical residues. But that specificity means cocktails must cover the strain diversity in your environment, and there’s always the question of whether your plant’s Listeria matches the cocktail’s host range. Suppliers design for breadth, but verification against your own isolates is the responsible step.

Resistance deserves a clear-eyed mention. Bacteria can develop phage resistance, just as they do with sanitizers and antibiotics — the literature documents it. The practical answer is the same as with any antimicrobial: rotate or combine approaches, don’t rely on a single hurdle, and monitor. Used as one layer in a Listeria control program — alongside sanitation, hygienic zoning, and environmental monitoring — phage products are a legitimate additional hurdle. Used as the program, they’re a gamble.

Source: Leverentz B, et al. (2003). Biocontrol of Listeria monocytogenes on fresh-cut produce by treatment with lytic bacteriophages and a bacteriocin. Appl Environ Microbiol, 69(8), 4519–4526. DOI: 10.1128/AEM.69.8.4519-4526.2003.